Skip to content
10-Q

Quarterly Report

SHENGTAI PHARMACEUTICAL, INC.

0001144204-12-029220

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · May 11, 2012 9.58M sh
Short Term Debt Q3 2012 · Mar 31, 2012 $60.92M
Short Term Debt Q3 2012 · Jun 30, 2011 $48.09M
Stockholders Equity Q3 2012 · Mar 31, 2012 $62.17M
Stockholders Equity Q3 2012 · Jun 30, 2011 $59.62M
Current Liabilities Q3 2012 · Mar 31, 2012 $95.4M
Current Liabilities Q3 2012 · Jun 30, 2011 $84.62M
Current Assets Q3 2012 · Mar 31, 2012 $60.08M
Current Assets Q3 2012 · Jun 30, 2011 $48.09M
Total Assets Q3 2012 · Mar 31, 2012 $157.57M
Total Assets Q3 2012 · Jun 30, 2011 $144.24M
Operating Cash Flow Q3 2012 · Mar 31, 2011 $2.57M
Cash And Equivalents Q3 2012 · Mar 31, 2011 $2.24M
Cash And Equivalents Q3 2012 · Jun 30, 2010 $4.12M
Sga Expense Q3 2012 · Mar 31, 2011 $2.49M
Sga Expense Q3 2012 · Mar 31, 2011 $7.18M
Net Income Q3 2012 · Mar 31, 2011 $2.31M
Net Income Q3 2012 · Mar 31, 2011 $6.64M
Operating Income Q3 2012 · Mar 31, 2011 $3.94M
Operating Income Q3 2012 · Mar 31, 2011 $11.17M
Gross Profit Q3 2012 · Mar 31, 2011 $6.43M
Gross Profit Q3 2012 · Mar 31, 2011 $18.35M
Cost Of Revenue Q3 2012 · Mar 31, 2011 $35.26M
Cost Of Revenue Q3 2012 · Mar 31, 2011 $107.03M
Revenue Q3 2012 · Mar 31, 2011 $41.69M
Revenue Q3 2012 · Mar 31, 2011 $125.38M